LYEL
Price
$1.17
Change
-$0.05 (-4.13%)
Updated
Nov 12 closing price
105 days until earnings call
NTLA
Price
$16.65
Change
-$0.85 (-4.86%)
Updated
Nov 12 closing price
99 days until earnings call
Ad is loading...

LYEL vs NTLA

Header iconLYEL vs NTLA Comparison
Open Charts LYEL vs NTLABanner chart's image
Lyell Immunopharma
Price$1.17
Change-$0.05 (-4.13%)
Volume$1.11M
CapitalizationN/A
Intellia Therapeutics
Price$16.65
Change-$0.85 (-4.86%)
Volume$2.64M
CapitalizationN/A
LYEL vs NTLA Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LYEL vs. NTLA commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongSell and NTLA is a StrongSell.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (LYEL: $1.16 vs. NTLA: $16.65)
Brand notoriety: LYEL and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 86% vs. NTLA: 117%
Market capitalization -- LYEL: $323.9M vs. NTLA: $1.7B
LYEL [@Biotechnology] is valued at $323.9M. NTLA’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $492.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 6 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -6.45% price change this week, while NTLA (@Biotechnology) price change was +7.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.29%. For the same industry, the average monthly price growth was +11.71%, and the average quarterly price growth was +7.79%.

Reported Earning Dates

LYEL is expected to report earnings on Feb 26, 2025.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+1.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.7B) has a higher market cap than LYEL($324M). LYEL YTD gains are higher at: -40.206 vs. NTLA (-45.392). LYEL has higher annual earnings (EBITDA): -205.56M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. LYEL (491M). LYEL has less debt than NTLA: LYEL (53.3M) vs NTLA (106M). NTLA has higher revenues than LYEL: NTLA (46M) vs LYEL (54K).
LYELNTLALYEL / NTLA
Capitalization324M1.7B19%
EBITDA-205.56M-514.18M40%
Gain YTD-40.206-45.39289%
P/E RatioN/AN/A-
Revenue54K46M0%
Total Cash491M691M71%
Total Debt53.3M106M50%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELNTLA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGAIX38.670.81
+2.14%
Baron Global Advantage Institutional
KLCKX19.930.12
+0.61%
Federated Hermes Kaufmann Large Cap R
FAPMX13.84N/A
N/A
Fidelity Advisor Healthy Future I
VGRIX83.57-0.61
-0.72%
JPMorgan US Value A
AOTCX30.49-0.55
-1.77%
Virtus Emerging Markets Opps C

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with QSI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-4.13%
QSI - LYEL
48%
Loosely correlated
-22.41%
NTLA - LYEL
46%
Loosely correlated
-4.86%
VCYT - LYEL
46%
Loosely correlated
-1.65%
PGEN - LYEL
46%
Loosely correlated
-5.86%
ADPT - LYEL
45%
Loosely correlated
-8.47%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-4.86%
VCYT - NTLA
69%
Closely correlated
-1.65%
EDIT - NTLA
68%
Closely correlated
-6.97%
BEAM - NTLA
67%
Closely correlated
-7.94%
CRSP - NTLA
64%
Loosely correlated
-7.53%
PRME - NTLA
58%
Loosely correlated
-1.59%
More